Cargando…
Lidocaine enhances the effects of chemotherapeutic drugs against bladder cancer
This study aimed to investigate whether lidocaine, alone or in combination with other chemotherapeutic agents, inhibits the growth of human bladder cancer cells in vitro and orthotopically transplanted bladder tumors in vivo. The effects of lidocaine (1.25, 2.5 or 5 mg/mL), mitomycin C (MMC, 0.66 mg...
Autores principales: | Yang, Xihua, Zhao, Lili, Li, Meiping, Yan, Lei, Zhang, Shengwan, Mi, Zhenguo, Ren, Liansheng, Xu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766619/ https://www.ncbi.nlm.nih.gov/pubmed/29330444 http://dx.doi.org/10.1038/s41598-017-19026-x |
Ejemplares similares
-
Protosappanin B promotes apoptosis and causes G(1) cell cycle arrest in human bladder cancer cells
por: Yang, Xihua, et al.
Publicado: (2019) -
Asiaticoside Antagonizes Proliferation and Chemotherapeutic Drug Resistance in Hepatocellular Carcinoma (HCC) Cells
por: Ma, Ying, et al.
Publicado: (2020) -
A Potent Chemotherapeutic Strategy with Eg5 Inhibitor against Gemcitabine Resistant Bladder Cancer
por: Sun, Liang, et al.
Publicado: (2015) -
Repositioning Lidocaine as an Anticancer Drug: The Role Beyond Anesthesia
por: Zhou, Daipeng, et al.
Publicado: (2020) -
Relevance of the drug–drug interactions between lidocaine and the pharmacokinetic enhancers ritonavir and cobicistat
por: Dekkers, Bart G.J., et al.
Publicado: (2019)